Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michał Mielnik
Observed names:
M Mielnik,
M. Mielnik,
Michal Mielnik,
Mielnik, Michał
Institution:
Medical University of Lublin
Observed institutions:
Medical University of Lublin,
The University of Sydney,
Universidade de São Paulo,
Royal Prince Alfred Hospital,
Instituto do Câncer do Estado de São Paulo,
Universidade da Região de Joinville,
Medical University of Lodz,
Pomeranian Medical University
show all 8
ORCID:
0000-0003-4473-5319
Observed ORCID:
0000-0003-4473-5319
OpenAlex ID:
A5103096912
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
2024
·
Vania Hungria
, Pawel Robak
, et al.
·
New England Journal of Medicine
·
234
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
2025
·
Vania Hungria
, Paweł Robak
, et al.
·
The Lancet Oncology
·
50
ACE Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple Myeloma
2019
·
Szymon Zmorzynski
, Aneta Szudy-Szczyrek
, et al.
·
Frontiers in Oncology
·
34
PDF
Male gender and age range 20–29 years are the most important non-modifiable risk factors for recurrence after primary post-traumatic shoulder dislocation
2018
·
Karol Szyluk
, Andrzej Jasiński
, et al.
·
Knee Surgery Sports Traumatology Arthroscopy
·
26
Serum brain‐derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients
2020
·
Aneta Szudy‐Szczyrek
, Radosław Mlak
, et al.
·
British Journal of Haematology
·
25
Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen
2020
·
Aneta Szudy-Szczyrek
, Radosław Mlak
, et al.
·
Annals of Hematology
·
25
PDF
Results of Arthroscopic Bankart Lesion Repair in Patients with Post-Traumatic Anterior Instability of the Shoulder and a Non-Engaging Hill-Sachs Lesion with a Suture Anchor after a Minimum of 6-Year Follow-Up
2015
·
Karol Szyluk
, Andrzej Jasiński
, et al.
·
Medical Science Monitor
·
21
PDF
Belantamab Mafodotin, Bortezomib, and Dexamethasone Vs Daratumumab, Bortezomib, and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Overall Survival Analysis and Updated Efficacy Outcomes of the Phase 3 Dreamm-7 Trial
2024
·
Vania Hungria
, Pawel Robak
, et al.
·
Blood
·
19
The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients
2023
·
Michał Mielnik
, Aneta Szudy-Szczyrek
, et al.
·
Biomedicines
·
19
PDF
Can atopy have a protective effect against cancer?
2020
·
Andrzej Bożek
, Jerzy Jarzab
, et al.
·
PLoS ONE
·
19
PDF
The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides
2017
·
Ewelina Grywalska
, Iwona Smarz-Widelska
, et al.
·
Archivum Immunologiae et Therapiae Experimentalis
·
18
PDF
CTLA-4 Expression Inversely Correlates with Kidney Function and Serum Immunoglobulin Concentration in Patients with Primary Glomerulonephritides
2019
·
Ewelina Grywalska
, Iwona Smarz-Widelska
, et al.
·
Archivum Immunologiae et Therapiae Experimentalis
·
16
PDF
Phase I Study of Belantamab Mafodotin in Combination with Standard of Care in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Dreamm-9 Updated Interim Analysis
2024
·
Saad Z. Usmani
, Michal Mielnik
, et al.
·
Blood
·
14
PDF
Incidence of Posttraumatic Shoulder Dislocation in Poland
2016
·
Karol J. Szyluk
, Andrzej Jasiński
, et al.
·
Medical Science Monitor
·
13
PDF
Podstawowe techniki preparacyjne w sonochirurgii
2014
·
Zbigniew Pilecki
, Bogdan Koczy
, et al.
·
Journal of Ultrasonography
·
12
PDF
Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide‐based chemotherapy in multiple myeloma patients
2019
·
Radosław Mlak
, Aneta Szudy‐Szczyrek
, et al.
·
British Journal of Haematology
·
11
Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease
2018
·
Ewelina Grywalska
, Małgorzata Bartkowiak-Emeryk
, et al.
·
Advances in Clinical and Experimental Medicine
·
11
PDF
Subpopulations of natural killer-T-like cells before and after surgical treatment of laryngeal cancer
2017
·
Janusz Klatka
, Ewelina Grywalska
, et al.
·
Central European Journal of Immunology
·
11
PDF
Arthroscopy for anterolateral soft tissue impingement of the ankle joint.
2009
·
Bogdan Koczy
, Michał Pyda
, et al.
·
PubMed
·
11
A phase 1 study of belantamab mafodotin in combination with standard of care in newly diagnosed multiple myeloma: An interim analysis of DREAMM-9.
2023
·
Saad Zafar Usmani
, Michał Mielnik
, et al.
·
Journal of Clinical Oncology
·
9
PDF
SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak
2022
·
Izabela Korona-Głowniak
, Michał Mielnik
, et al.
·
International Journal of Environmental Research and Public Health
·
9
PDF
NK and NKT-Like Cells in Patients with Recurrent Furunculosis
2017
·
Danuta Nowicka
, Ewelina Grywalska
, et al.
·
Archivum Immunologiae et Therapiae Experimentalis
·
9
PDF
ABBV-383 Plus Daratumumab-Dexamethasone in Relapsed or Refractory Multiple Myeloma: A Phase 1b Dose-Escalation and Safety Expansion Study
2024
·
Cesar Rodriguez
, Michal Mielnik
, et al.
·
Blood
·
8
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma
2022
·
Aneta Szudy-Szczyrek
, Radosław Mlak
, et al.
·
Cells
·
8
PDF
Belantamab mafodotin does not induce B-cell maturation antigen loss or systemic immune dysfunction in multiple myeloma
2025
·
Hanny Musa
, Michał Mielnik
, et al.
·
Haematologica
·
7
Show more works
View as search
Works count:
54
Citation count:
694
H-index:
13
I10-index:
19
Year
Topic
Type